PNPLA3 and metabolic dysfunction-associated steatotic liver disease: PNPLA3 G allele carriers in NAFLD patients exhibit more severe forms of the disease, and the prevalence of advanced liver fibrosis, cirrhosis, and HCC is higher among them.